Iowa Oncology Research Association

Recent papers from Iowa Oncology Research Association

1. A URCC NCORP Research Base nationwide phase II randomized controlled trial (RCT) investigating the effect of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN).Journal of Clinical Oncology · 2026
2. International uptake of partnering for change (P4C): a Dutch and Swedish adapted versionScandinavian Journal of Educational Research · 2026
3. Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon CancerNew England Journal of Medicine · 2026
4. Operational efficiencies of using one vs multiple bispecific antibodies for diffuse large B-cell lymphoma and follicular lymphoma in the US.2026
5. Oncology pharmacist survey: Understanding task value and professional satisfactionJournal of Oncology Pharmacy Practice · 2026
6. Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer TreatmentJournal of Adolescent and Young Adult Oncology · 2026
7. Exploring Rurality and Racial/Ethnic Disparities in Texas Mortality: A Scoping Review of the Five Leading Causes of DeathJournal of Racial and Ethnic Health Disparities · 2025
8. Insights from the front line: uplifting stories of the COVID-19 pandemic through the eyes of the public health workforce in IowaFrontiers in Public Health · 2025
9. Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).Journal of Clinical Oncology · 2025
10. Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD)BMJ Open · 2025
11. Care Coordination for Mosunetuzumab Therapy in Patients With Follicular Lymphoma in Community Practices: Learnings From the MorningSun Study InvestigatorsCancer Medicine · 2025
12. Time to complete oncology pharmacist tasks: A joint opinion of the Hematology/Oncology Pharmacy Association and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research NetworkJournal of Oncology Pharmacy Practice · 2025
13. Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysisExperimental Hematology and Oncology · 2025
14. Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck CancerJAMA Network Open · 2024
15. Development of oral oncolytic nonadherence estimator (ORACLE): A pretreatment nonadherence risk assessment for oral oncolyticsJournal of Oncology Pharmacy Practice · 2023
16. Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)Cancer Medicine · 2023
17. Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2JCO Precision Oncology · 2023
18. Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal CancerCancer Control · 2023
19. Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor PrescribingJAMA Network Open · 2022
20. A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile NeutropeniaJournal of Clinical Oncology · 2022